Q--NGS services to support clinical research

The National Institutes of Health (NIH) Office of the Director, Office of Acquisitions, is seeking Next-Generation Sequencing (NGS) services to support clinical research projects. This requirement, issued under solicitation number 75N98026Q00369, is a combined synopsis and solicitation for commercial services. The government intends to award a firm-fixed-price purchase order to the responsible offeror whose proposal represents the best value. This acquisition is conducted using streamlined procedures and is not expected to exceed the simplified acquisition threshold.

The procurement is classified under NAICS code 621511 for Medical Laboratories and PSC Q301 for Medical- Laboratory Testing. This requirement is set aside for small business concerns under the Small Business Administration (SBA) set-aside program. Evaluation and award will be based on Federal Acquisition Circular 2026-01, and the government does not intend to issue a separate written solicitation beyond this announcement and its associated documentation.

The response deadline for this opportunity is May 29, 2026. Nicholas S. Capobianco serves as the primary point of contact for this requirement. The solicitation includes five attachments, including the original solicitation document and three subsequent amendments issued between May 15 and May 22, 2026. All incorporated provisions and clauses are those in effect as of March 13, 2026.